Back to Journals » OncoTargets and Therapy » Volume 13

Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer

Total article views   HTML views PDF downloads Totals
5,676 Dovepress* 4,703+ 958 5,661
PubMed Central* 973 267 1,240
Totals 5,676 1,225 6,901
*Since 13 November 2020

View citations on PubMed Central and Google Scholar